| Acute Leukemia |
1 |
1 |
| Biologic Therapy |
0 |
0.98 |
| Antineoplastic Drug |
0 |
0.94 |
| Tyrosine Kinase Inhibitor |
0 |
0.99 |
| Stem Cell Research and Therapy |
0 |
0.46 |
| Chemotherapy |
0 |
0.38 |
| Combination Chemotherapy |
0 |
0.31 |
| Cell Transplantation |
0 |
0.23 |
| Genomic Medicine |
0 |
0.22 |
| Transplantation |
0 |
0.16 |
| Cancer |
0 |
0.11 |
| Europe |
0 |
0.11 |
| Toxicology |
0 |
0.11 |
| Cardiovascular Risk Management |
0 |
0.09 |
| Acute Lymphoblastic Leukemia |
0 |
0.08 |